Læknablaðið - 15.08.1991, Side 39

LÆKNABLAÐIÐ
245
BJ. An outbreak of erythema infectiosum associated
with human parvovirus infection. J Hyg (Lond) 1984;
93: 85-93.
27. Anderson MJ, Higgins PG, Davis LR, et al.
Experimental parvoviral infection in man. J Infect
Dis 1985; 152:'257-65.
28. Woolf AD, Campion GV, Chishick A, et al. Clinical
manifestations of human parvovirus B19 in adults.
Arch Intem Med 1989; 149 (5); 1153-6.
29. Cohen BJ, Buckley MM, Clewley JP, Jones VE,
Puttick AH, Jacoby RK. Human parvovirus infection
in early rheumatoid and inflammatory arthritis. Ann
Rheum Dis 1986; 45 (10); 832-8.
30. Brown T, Anand A, Ritchie LD, Clewley JP, Reid
TMS. Intrauterine parvovirus infection associated
with hydrops fetalis. (Letter). Lancet 1984; 2: 1033-4.
31. Samra JS, Obhrai MS, Constanline G. Parvovirus
infection in pregnancy. Obstet Gynecol 1989; 73 (5
Pt 2); 832-4.
32. Caul OE, User MJ, Burton PA. Intrauterine infection
with human parvovims B19: A light and electron
microscopy study. J Med Virol 1988; 24: 55-66.
33. Risks associated with human parvovirus B19
infection. MMWR 1989; 38 (6); 81-97.
34. Cohen BJ, Buckley MM. The prevalence of antibody
to human parvovirus B19 in England and Wales. J
Med Microbiol 1988; 25: 151-3.
35. Plummer FA, Hammond GW, Forward K, et al. An
erythema infectiosum-like illness caused by human
parvovims infection. N Engl J Med 1985; 313: 74-9.
36. Gillespie M, Cartter L, Asch S, et al. Occupational
risk of human parvovirus B19 infection for school
and day-care personnel during an outbreak of
erythema infectiosum. JAMA 1990; (15); 2061-5.
37. Woemle CH, Anderson LJ, Tattersall P, Davison JM.
Human parvovims B19 infection during pregnancy. J
Infect Dis 1987; 156 (1); 17-20.
38. Kinney JS, Anderson LJ, Farrar J, et al. Risk
of adverse outcomes of pregnancy after human
parvovims B19 infection. J Infect Dis 1988; 157 (4);
663-7.
39. Mortimer PP, Cohen BJ, Buckley MM, et al. Human
parvovims and the fetus. (Letter). Lancet 1985; 2:
1012.
40. Anderson MJ. Human parvovimses. In: Zuckerman
AJ, Banatvala JE, Pattison JR, eds. Principles and
Practice of Clinical Virology. Chichester, New York,
Brisbane, Toronto, Singapore: John Wiley and Sons
Ltd. 1987; 14: 507-16.
41. Bell LM, Naides SJ, Stoffman P, Hodinka RL,
Plotkin SA. Human parvovims B19 infection among
hospital staff members after contact with infected
patients. N Engl J Med 1989; 321 (8); 485-91.
42. Schwarz TF, Roggendorf M, Hottentráger B, Modrow
S, Deinhardt F, Middeldorp J. Immunoglobulins in
the prophylaxis of parvovims B19 infection. J Infect
Dis 1990; 162: 1214.
43. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas
R, Young NS. Chronic bone marrow failure due to
persistent B19 parvovims infection. N Engl J Med
1987; 317: 287-94.
44. Kurtzman GJ, Frickhofen N, Kimball J, Jenkins DW,
Nienhuis AW, Young NS. Pure red-cell aplasia of
10 years’ duration due to persistent parvovims B19
infection and its cure with immunoglobulin therapy.
N Engl J Med 1989; 321 (8); 519-23.
45. Frickhofen N, Abkowitz L, Safford M, et al.
Persistent B19 parvovims infection in patients
infected with human immunodeficiency virus type
1 (HIV-1); A treatable cause of anemia in AIDS. Ann
Intem Med 1990; 113 (12); 926-33.
46. Kurtzman G, Cohen B, Myers P, Amanullah A,
Young N. Persistent B19 parvovims infection as
a cause of severe anemia in children with acute
lymphocytic leukemia in remission. Lancet 1988; 2:
1159-62.
47. Belloy M, Morinet F, Blondin G, Courouce AM,
Peyrol Y, Vilmer E. Erythroid hypoplasia due to
chronic infection with parvovims BÍ9. N Engl J Med
1990; 322 (9); 633-4.
48. Simpson RW, McGinty L, Simon L, Smith CA,
Godzeski CW, Boyd RJ. Association of parvovimses
with rheumatoid arthritis of humans. Science 1984;
223: 1425-8.